April 25, 2024

Costaalegre Restaurant

Learn marketing business

38 Stocks Moving in Friday’s Pre-Market Session

4 min read
38 Stocks Moving in Friday's Pre-Market Session

Table of Contents

Gainers

  • Entera Bio Ltd. (NASDAQ: ENTX) shares rose 51.7% to $6.13 in pre-market trading. Entera Bio shares climbed over 152% on Thursday after the company disclosed positive topline EB613 Phase 2 biomarker data. The company is set to release results for the year ended December 30, 2020 on March 18, 2021.
  • GigaMedia Limited (NASDAQ: GIGM) rose 48.9% to $5.24 in pre-market trading after gaining 8% on Thursday.
  • Fujian Blue Hat Interactive Entertainment Technology Ltd.. (NASDAQ: BHAT) rose 27.1% to $1.78 in pre-market trading.
  • Marrone Bio Innovations, Inc. (NASDAQ: MBII) rose 25.5% to $3.15 in pre-market trading after gaining around 8% on Thursday. The company is scheduled to release Q4 results on March 23.
  • Altimmune, Inc. (NASDAQ: ALT) shares rose 24.8% to $21.06 in pre-market trading after the company reported expansion of AdCOVID manufacturing collaboration with Lonza.
  • Novavax, Inc. (NASDAQ: NVAX) rose 20.3% to $225.67 in pre-market trading after the company reported that its COVID-19 vaccine, NVX-CoV2373, was 96.4% effective “against mild, moderate and severe disease caused by the original COVID-19 strain” in Phase 3 trials.
  • DBV Technologies S.A. (NASDAQ: DBVT) rose 14.3% to $5.99 in pre-market trading after the company reported financial results for the year ended December 31, 2020.
  • ContraFect Corporation (NASDAQ: CFRX) rose 13.2% to $7.18 in pre-market trading after the company announced it was awarded a BARDA contract for up to $86.8 million.
  • Oncternal Therapeutics, Inc. (NASDAQ: ONCT) shares rose 13% to $7.20 in pre-market trading after the company reported better-than-expected Q4 results.
  • Iterum Therapeutics plc (NASDAQ: ITRM) rose 11.7% to $1.79 in pre-market trading.
  • Torchlight Energy Resources, Inc. (NASDAQ: TRCH) rose 10.7% to $3.01 in pre-market trading after jumping over 20% on Thursday.
  • Funko, Inc. (NASDAQ: FNKO) rose 10.1% to $16.88 in pre-market trading after reporting an increase in quarterly earnings.
  • Creative Realities, Inc. (NASDAQ: CREX) rose 9.5% to $2.31 in pre-market trading after climbing around 12% on Thursday. The company recently released Q4 results.
  • Seelos Therapeutics, Inc. (NASDAQ: SEEL) rose 8.9% to $3.31 in pre-market trading as BTIG initiated coverage on the stock with Buy rating and $14 price target.
  • Energy Recovery, Inc. (NASDAQ: ERII) rose 8.1% to $20.39 in pre-market trading after reporting upbeat quarterly results.

 

Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • New Oriental Education & Technology Group Inc. (NYSE: EDU) fell 90% to $16.85 in pre-market trading after dropping around 90% on Thursday.
  • Timber Pharmaceuticals, Inc. (NASDAQ: TMBR) fell 25.1% to $2.66 in pre-market trading after surging over 75% on Thursday.
  • Marker Therapeutics, Inc. (NASDAQ: MRKR) fell 24.9% to $1.90 in pre-market trading after the company reported a common stock offering.
  • Evoke Pharma, Inc. (NASDAQ: EVOK) fell 22.6% to $2.40 in pre-market trading after reporting a loss for the fourth quarter.
  • FinVolution Group (NYSE: FINV) fell 15.4% to $8.27 in pre-market trading. FinVolution Group surged 93% on Thursday after the company reported Q4 results.
  • AMMO, Inc. (NASDAQ: POWW) fell 15% to $5.76 in pre-market trading after reporting a common stock offering.
  • Poshmark, Inc. (NASDAQ: POSH) fell 14.2% to $51.01 in pre-market trading after the company reported Q4 earnings results.
  • MediciNova, Inc.(NASDAQ: MNOV) fell 13.1% to $6.10 in pre-market trading. MediciNova shares rose over 50% on March 9th following an announcement the company partnered with BARDA to develop MN-166 as a medical countermeasure against chlorine gas-induced lung injury.
  • China HGS Real Estate Inc. (NASDAQ: HGSH) fell 11% to $2.02 in pre-market trading after jumping 26% on Thursday.
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) fell 10.8% to $7.02 in pre-market trading after the company announced a proposed public offering of common stock.
  • RYB Education, Inc. (NYSE: RYB) fell 10.8% to $4.46 in pre-market trading after jumping 43% on Thursday.
  • Histogen Inc. (NASDAQ: HSTO) fell 9.9% to $1.28 in pre-market trading after the company reported worse-than-expected Q4 sales.
  • Exela Technologies, Inc. (NASDAQ: XELA) fell 9.9% to $3.63 in pre-market trading. Exela Technologies recently said it won a 10-year, $90-million contract delivering data transformation solutions for a major US insurer.
  • Ulta Beauty, Inc. (NASDAQ: ULTA) fell 9.8% to $313.33 in pre-market trading after the company reported Q4 earnings results.
  • Super League Gaming, Inc. (NASDAQ: SLGG) shares fell 9.8% to $6.20 in pre-market trading after the company reported a wider-than-expected quarterly loss.
  • Auris Medical Holding Ltd. (NASDAQ: EARS) shares fell 9.7% to $3.61 in pre-market trading after declining 10% on Thursday.
  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) fell 9.7% to $4.46 in pre-market trading following wider-than-expected quarterly loss.
  • Phio Pharmaceuticals Corp. (NASDAQ: PHIO) fell 9.2% to $2.86 in pre-market trading after gaining over 10% on Thursday.
  • Dragon Victory International Limited (NASDAQ: LYL) fell 8.9% to $1.94 in pre-market trading after dropping over 5% on Thursday.
  • StoneCo Ltd. (NASDAQ: STNE) fell 8.2% to $70.08 in pre-market trading after the company reported Q4 earnings results.
  • ENGlobal Corporation (NASDAQ: ENG) fell 8.2% to $5.97 in pre-market trading. ENGlobal jumped around 44% on Thursday after Will Meade, a trader on Twitter with 165,000 followers, tweeted his support for the engineering services company..
  • Longeveron Inc. (NASDAQ: LGVN) fell 8.1% to $7.77 in pre-market trading. The company’s Lomecel-B was recently approved by the FDA for compassionate use for the treatment of child with hypoplastic left heart syndrome.
  • DocuSign, Inc. (NASDAQ: DOCU) fell 4.8% to $214.50 in pre-market trading after the company reported Q4 earnings results.

costaalegrerestaurant.com | Newsphere by AF themes.